Here's My Top Growth Stock to Buy for 2023 and Beyond
This has been an absolutely dismal year for growth stocks. The Vanguard Growth ETF has fallen about 33% over the past 12 months.
While times have been tough for most growth stocks, shares of TransMedics Group (NASDAQ: TMDX) have more than tripled in 2022. Investors reacted to exploding sales of its devices, and there are reasons to expect even stronger sales growth in 2023.
This might not be the flashiest stock out there, but it should be. It has a leading position in a healthcare niche ripe for disruption. Read on to see why I bought shares recently and will probably add more down the line.
Source Fool.com